Results 131 to 140 of about 4,769 (183)

Neural checkpoint therapy in lung cancer. [PDF]

Trends Cancer
Das G, Zhao H, Wong STC.
europepmc   +1 more source

Germinal Center-Like Tertiary Lymphoid Structures Mark Immune Responsiveness and Enable Checkpoint Immunotherapy in Bladder Cancer. [PDF]

Oncol Res
Yin Z, Zhen X, Li H, Duan H, Hu X, Yu T, Shi Q, Liu Z, Li Y, Zhang P, Dai P, Zhao M, Wang Z, Li C, Wang D, Tong Z.   +15 more
europepmc   +1 more source

Prognostic value of tertiary lymphoid structures in locally advanced esophageal squamous cell carcinoma treated with neoadjuvant chemoimmunotherapy: a retrospective study. [PDF]

J Cardiothorac Surg
Xue T, Wu Y, Zi Q, Zi T, Gao S, Mao J, Peng Y, Chen J, Wang X.   +8 more
europepmc   +1 more source

Comparative Analysis of Pathology Foundation Models for Automated Detection of Tertiary Lymphoid Structures in Hematoxylin-and-Eosin-Stained Digital Pathology Images. [PDF]

Comput Struct Biotechnol J
Guan M, Sun Y, Belete M, Muthuswamy A, Farma M, Kaufmann J, Lechpammer M, Sridhar S, Higgs BW, Si H.   +9 more
europepmc   +1 more source

Efficacy and challenges of immunotherapy in advanced <i>EGFR</i>-mutant NSCLC: a case report. [PDF]

Front Oncol
Su Y, Dong W, Yin Y, Qin J.
europepmc   +1 more source

Tertiary lymphoid structures in breast cancer: Mechanistic insights, subtype-specific patterns, and therapeutic implications. [PDF]

World J Surg Oncol
Liang Y, Wu K, Pan L, Jia M, Zhang W, Zhang X, Gao J.   +6 more
europepmc   +1 more source

Germinal center responses at barrier organ sites. [PDF]

Curr Opin Immunol
Foster WS, Nowosad CR.
europepmc   +1 more source

The predictive role of tertiary lymphoid structures in the prognosis and response to immunotherapy of bladder cancer patients: a systematic review and meta-analysis. [PDF]

BMC Cancer
Hu P, Wang C, Zeng X, Jin S, Huang J, Wang Q, Li X, Du Y, Song Y, Xu T.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A digital imaging analysis (DIA) platform for identifying tertiary lymphoid structures (TLS) in lung adenocarcinoma (LUAD).

Journal of Clinical Oncology, 2022
3142 Background: Previous studies of non-small cell lung cancer (NSCLC) have shown that TLS can be predictive of therapy response and a positive prognostic factor for survival. Currently, TLS identification is manually performed by pathologists with limited morphological criteria. Standardizing TLS detection with an automated DIA workflow could guide
Vladimir Kushnarev, Anna Belozerova, Daniil Dymov, Yuriy Popov, Nadezhda Lukashevich, Ivan Valiev, Diana Shamsutdinova, Aida Akaeva, Ilia Galkin, Lev Popyvanov, Viktor Svekolkin, Krystle Nomie, Anna Love, Alexander Bagaev, Ekaterina Postovalova, Nathan Fowler   +15 more
openaire   +1 more source